Faralimomab
Faralimomab (64G12) is an immunomodulator, and a murine anti-IFNA1 IgG1 mAb[1].
Product Specifications
CAS Number
[167816-91-3]
Product Name Alternative
64G12
UNSPSC
12352203
Target
IFNAR
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/faralimomab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Faralimomab]
Molecular Weight
(145.34 kDa)
References & Citations
[1]Pelletier J P R, et al. Passive monoclonal and polyclonal antibody therapies[M]//Immunologic Concepts in Transfusion Medicine. Elsevier, 2020: 251-348. |[2]Pelletier J P R, et al. Passive monoclonal and polyclonal antibody therapies[M]//Immunologic Concepts in Transfusion Medicine. Elsevier, 2020: 251-348.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6291761-01 0.2 mL
DEPDC7, CT (DEPDC7, DEP domain-containing protein 7, Protein TR2/D15) (AP)
Ask
View Details 
MBS6291761-02 5x 0.2 mL
DEPDC7, CT (DEPDC7, DEP domain-containing protein 7, Protein TR2/D15) (AP)
Ask
View Details